drugset / Trial / NCT04209803

N-Acetyl-Cysteine for Treatment of AGA in Men

NCT04209803

RandomizedFactorialSingle-blindTreatment

Summary

To study the effectiveness and safety of the reactive oxygen species scavenger N-acetyl-cysteine (NAC) as a single therapy and in combination with the topically applied minoxidil for the treatment of the early-onset androgenetic alopecia in men.

Timeline

Start
2018-12-01
Primary completion
2020-09-02
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minoxidil Small molecule 5 % Topical
Comparator N-acetylcysteine Small molecule 600 mg

Indications